Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia
- PMID: 15304082
- DOI: 10.1111/j.0022-202X.2004.23237.x
Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia
Abstract
Hair loss, as it occurs with telogen effluvium and androgenetic alopecia, provokes anxieties and distress more profound than its objective severity would appear to justify. This reflects the profound symbolic and psychosocial importance of hair. Stress has long been implicated as one of the causal factors involved in hair loss. Recently, in vivo studies in mice have substantiated the long-held popular belief that stress can exert profound hair growth-inhibitory catagen-inducing and hair-damaging pro-inflammatory effects. Insights into the negative impact of stress on hair growth and the integration of stress-coping strategies into the management of hair loss disorders as well as the development of new pharmacotherapeutic strategies might lead to enhanced therapeutic modalities with the alleviation of clinical symptoms as well as the concomitant psychological implications.
Similar articles
-
Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination.J Am Acad Dermatol. 2014 Sep;71(3):415.e1-415.e15. doi: 10.1016/j.jaad.2014.04.070. J Am Acad Dermatol. 2014. PMID: 25128118 Review.
-
[Diffuse hair loss in women].Ther Umsch. 2002 May;59(5):217-22. doi: 10.1024/0040-5930.59.5.217. Ther Umsch. 2002. PMID: 12090117 German.
-
Telogen effluvium.Indian J Dermatol Venereol Leprol. 2013 Sep-Oct;79(5):591-603. doi: 10.4103/0378-6323.116731. Indian J Dermatol Venereol Leprol. 2013. PMID: 23974577 Review.
-
Telogen effluvium.Dermatology. 1997;195(3):209-12. doi: 10.1159/000245944. Dermatology. 1997. PMID: 9407163 Review.
-
Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.Ann Agric Environ Med. 2024 Jun 27;31(2):239-247. doi: 10.26444/aaem/177238. Epub 2024 Jan 8. Ann Agric Environ Med. 2024. PMID: 38940108
Cited by
-
Type D Personality, Stress Levels, and Coping Strategies in Women with Androgenetic Alopecia and Polycystic Ovary Syndrome.Med Sci Monit. 2024 Aug 23;30:e944746. doi: 10.12659/MSM.944746. Med Sci Monit. 2024. PMID: 39175181 Free PMC article.
-
Zinc Status in Kurdish Adults With Hair Loss.Cureus. 2024 Aug 20;16(8):e67264. doi: 10.7759/cureus.67264. eCollection 2024 Aug. Cureus. 2024. PMID: 39165624 Free PMC article.
-
Physical Treatments and Therapies for Androgenetic Alopecia.J Clin Med. 2024 Aug 2;13(15):4534. doi: 10.3390/jcm13154534. J Clin Med. 2024. PMID: 39124800 Free PMC article. Review.
-
Postpartum Telogen Effluvium Unmasking Additional Latent Hair Loss Disorders.J Clin Aesthet Dermatol. 2024 May;17(5):15-22. J Clin Aesthet Dermatol. 2024. PMID: 38779373 Free PMC article.
-
Combating "dread shed": The impact of overlapping topical and oral minoxidil on temporary hair shedding during oral minoxidil initiation.JAAD Int. 2024 Mar 25;15:220-224. doi: 10.1016/j.jdin.2024.03.005. eCollection 2024 Jun. JAAD Int. 2024. PMID: 38707927 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical